TOKYO (AP) – Japanese government health officials inspected a production factory Sunday. Dietary supplements linked to at least 5 deaths More than 100 people were hospitalized the day after authorities investigated another factory that made the product.
A team of 17 national and prefectural health officials raided a factory operated by a subsidiary of Kobayashi Pharmaceutical Co., Ltd. in Kinokawa City, Wakayama Prefecture, based on the Food Sanitation Act. NHK public television showed workers entering the factory.
The Wakayama factory took over production of the supplement after Kobayashi Pharmaceutical closed another factory in nearby Osaka, according to NHK, and was raided by authorities on Saturday.
Kobayashi Pharmaceutical spokeswoman Yuko Toyama told reporters that the company is fully cooperating with the investigation.
The company says little is known about the exact causes of the disease, including kidney failure.
All of the supplements surveyed use “red yeast'', a type of red mold, and include Kobayashi Pharmaceutical's “red koji cholesterol help,'' a pink pill that claims to lower cholesterol levels. ing.
Osaka-based Kobayashi Pharmaceutical said it has sold about 1 million packages in the past three fiscal years. The company also sells red yeast rice to other manufacturers, and some products are exported. Supplements can be purchased at drug stores without a doctor's prescription.
Red yeast rice has been used in a variety of products for years, but reports of health issues surfaced in 2023.
The recall took place on March 22nd., two months after the company received an official medical report on the issue. The company's president, Akihiro Kobayashi, apologized for not acting sooner.
The company announced Friday that five people have died and 114 people are being treated in hospitals after ingesting the product.
Japan's Ministry of Health and Welfare said the supplements may be causing death and illness and warned that the number of people affected could rise further. The government has ordered a review of the approval system in response to supplement-related illnesses.
Some analysts blame recent deregulatory efforts that have simplified and sped up approval of health products to promote economic growth. Fatal accidents involving mass-produced products are rare in Japan, where government inspections of consumer products are relatively strict.
___
According to the agency, this article corrects previous statements that the supplement caused death or illness. Japanese health authorities suspect that supplements are the cause, but have not yet determined for sure.
___
Associated Press writer Mari Yamaguchi contributed to this report.
___
Yuri Kageyama is in X: https://twitter.com/yurikageyama
